BioNTech SE Increase Decrease Through Business Combinations Deferred Tax Liability Asset
BioNTech SE (BNTX) reported Increase Decrease Through Business Combinations Deferred Tax Liability Asset of EUR 17.90 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes › Income Taxes
ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset · last filed 2026-03-10
| Period end | Increase Decrease Through Business Combinations Deferred Tax Liability Asset 12 month | Increase Decrease Through Business Combinations Deferred Tax Liability Asset 12 month as first filed |
|---|---|---|
| 2025-12-31 | 17.90M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | -169.10M EUR 20-F · filed 2025-03-10 | |
| 2022-12-31 | 179.90M EUR 20-F · filed 2024-03-20 | |
| 2021-12-31 | -8.80M EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 100.00K EUR 20-F/A · filed 2022-10-26 | -19.00K EUR 20-F · filed 2021-03-30 |